cardiovascular benefits of glp-1 drugs like semaglutide and tirzepatide have surged in popularity for diabetes and weight loss — now used by about 1 in 8 U.S. adults and known to protect the heart. ⁠ ⁠ Cardiovascular Protection with a Long-Acting

10.1016/j.jdermsci.2020.03.001 180

Its important to log temperature data consistently to verify storage conditions

Choose formulas with moderate caffeine levels, around 150 to 200mg per serving, rather than high-stimulant products at 300mg or above

Key Educational Points: Emphasize the experimental nature No clinical trials support this combination Highlight individual compound efficacy Both peptides show strong effects as monotherapies Discuss approved alternatives CagriSema and other studied combinations offer evidence-based options Explain regulatory status Neither compound has FDA approval for metabolic applications as of 2026 Address safety concerns Overlapping side effect profiles create legitimate risks When clients express interest in research peptides, directing them toward compounds with established safety profiles and dosing protocols serves their best interests